Joint Conference Ramathibodi - Hokkaido - Osaka University
Intended for |
|
|---|---|
Date | 2022.11.2 Wed 11:00 - 16:40 |
Venue | |
How to apply | Application Form |
Contact | Center for Global Health, Department of Medical Innovation, Osaka University Hospital 06-6879-4128 (Suita 3396) |
The Joint Conference Ramathibodi – Hokkaido - Osaka University will be held as a hybrid conference on November 2.
This year, the conference is on “Development of International Human Clinical Research” and will cover topics such as PPI (Patient and Public Involvement), cancer, infectious disease, and medical devices.
To register for the symposium, submit an application form using the URL below:
https://forms.office.com/r/1TCaXBLcLL
- Date: November 2, 2022
- Format of the conference: Hybrid (Online & Onsite)
- Onsite venue: Hokkaido University, School of Medicine, The Alumni Hall “Frate”
- Registration fee: Free of charge
- Language: English
Speakers (partial list)
■ Prof. Beverley Anne Yamamoto
(Director of OU UNESCO Chair in Global Health and Education, Osaka University)
“The benefits and challenges of implementing patient and public involvement in medical research and policy making: Introducing three projects at Osaka University”
■ Asst.Prof. Kamthorn Malathum
(Deputy Director, Ramathibodi Hospital)
“The Unmet Needs in Antimicrobial Resistance Therapy and Prevention”
■ Ms. Nisa Tania Tabassum
(Specially appointed researcher, Center for Global Health, Osaka University Hospital)
“Carbapenemase-producing Enterobacteriaceae in the environment of Dhaka, Bangladesh: a call to action”
■ Dr. Takako Miyamura
(Department of Pediatrics, Graduate School of Medicine, Osaka University)
“International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia”
■ Prof. Suradej Hongeng
(Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University)
“From omics to drug discovery”
■ Dr. Gajanan Revankar
(Department of Neurology, Osaka University)
“Patient-centric approach to utilizing visual misperception as a marker for neuropsychiatric disease – ‘RealVision’ study”
For more details, please access the URL below:
http://www.gcrso.med.osaka-u.ac.jp/en/news/fy2022-symposium-1/